Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
CMS may cover TAVR for aortic regurgitation | FDA approves CardioMEMS updates | Lilly's GLP-1 pill | Celebrating outpatient care
Tuesday, October 6, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CMS considers covering TAVR for aortic regurgitation

CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

CMS considers covering TAVR for aortic regurgitation

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 
READ MORE >

FDA approves updates to Abbott’s CardioMEMS heart failure platform

Heart failure patients with a CardioMEMS implant can now monitor their own pulmonary artery pressure readings and receive clinician feedback through a smartphone app.

READ MORE >
CardioMEMS Abbott heart failure
Share on Twitter Share on Facebook Share on Linkedin

FDA approves updates to Abbott’s CardioMEMS heart failure platform

Share on Twitter Share on Facebook Share on Linkedin
CardioMEMS Abbott heart failure
Heart failure patients with a CardioMEMS implant can now monitor their own pulmonary artery pressure readings and receive clinician feedback through a smartphone app.
READ MORE >

A big win for Foundayo: GLP-1 pill orforglipron helps patients lose weight, protect their hearts

Orforglipron was linked to consistent weight loss in addition to reductions in waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol and high-sensitivity C-reactive protein. In terms of safety, it was found to be noninferior to insulin glargine.

READ MORE >
doctor with overweight patient who may be treated with TAVR or surgery
Share on Twitter Share on Facebook Share on Linkedin

A big win for Foundayo: GLP-1 pill orforglipron helps patients lose weight, protect their hearts

Share on Twitter Share on Facebook Share on Linkedin
doctor with overweight patient who may be treated with TAVR or surgery
Orforglipron was linked to consistent weight loss in addition to reductions in waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol and high-sensitivity C-reactive protein. In terms of safety, it was found to be noninferior to insulin glargine.
READ MORE >

American Heart Association celebrates high-quality outpatient care

The AHA recognized more than 2,700 U.S. healthcare organizations for managing patients with high blood pressure, high cholesterol and/or type 2 diabetes. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association celebrates high-quality outpatient care

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
The AHA recognized more than 2,700 U.S. healthcare organizations for managing patients with high blood pressure, high cholesterol and/or type 2 diabetes. 
READ MORE >

Featured Articles

More and more young children now taking GLP-1 drugs for weight loss

Some parents may be unsure about giving their children these medications. However, it can be worth it to avoid a lifetime of high blood pressure and other potentially harmful health conditions.

READ MORE >
weight loss scale overweight obese lose weight pounds
Share on Twitter Share on Facebook Share on Linkedin

More and more young children now taking GLP-1 drugs for weight loss

Share on Twitter Share on Facebook Share on Linkedin
weight loss scale overweight obese lose weight pounds
Some parents may be unsure about giving their children these medications. However, it can be worth it to avoid a lifetime of high blood pressure and other potentially harmful health conditions.
READ MORE >

American College of Cardiology wants clinicians to feel ‘safe, supported and respected’

Research has shown that mistreatment at the hands of patients and other visitors is one of the leading drivers of burnout in the U.S. healthcare system. The new Cardio Safe initiative was built to combat that issue and protect the well-being of cardiologists and other cardiovascular health professionals. 

READ MORE >
burnout stress work staffing
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology wants clinicians to feel ‘safe, supported and respected’

Share on Twitter Share on Facebook Share on Linkedin
burnout stress work staffing
Research has shown that mistreatment at the hands of patients and other visitors is one of the leading drivers of burnout in the U.S. healthcare system. The new Cardio Safe initiative was built to combat that issue and protect the well-being of cardiologists and other cardiovascular health professionals. 
READ MORE >

New heart attack drug submitted to FDA for review

A new STEMI medication from CeleCor Therapeutics is now one step closer to a potential FDA approval.

READ MORE >
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Share on Twitter Share on Facebook Share on Linkedin

New heart attack drug submitted to FDA for review

Share on Twitter Share on Facebook Share on Linkedin
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
A new STEMI medication from CeleCor Therapeutics is now one step closer to a potential FDA approval.
READ MORE >

Mount Sinai researchers aim to learn more about treating SCAD

There is still not a clear consensus on how to best treat this atypical cardiac presentation.

READ MORE >
Spontaneous coronary artery dissection (SCAD) is a sudden tears in the wall of a coronary arteries can reduce blood flow and cause an uncommon type of heart attack, often in women. However, there is not a clear consensus on how to best treat this atypical cardiac presentation.
Share on Twitter Share on Facebook Share on Linkedin

Mount Sinai researchers aim to learn more about treating SCAD

Share on Twitter Share on Facebook Share on Linkedin
Spontaneous coronary artery dissection (SCAD) is a sudden tears in the wall of a coronary arteries can reduce blood flow and cause an uncommon type of heart attack, often in women. However, there is not a clear consensus on how to best treat this atypical cardiac presentation.
There is still not a clear consensus on how to best treat this atypical cardiac presentation.
READ MORE >

In Case You Missed It

How to close outcome gaps in cardiovascular care

It's important to remember that there is no one-size-fits-all solution when it comes to patient care. What works is some communities may not work in others.

READ MORE >
Anekwe Onwuanyi, MD, FACC, American Heart Association volunteer, Professor of Medicine and Chief of Cardiology, at Morehouse School of Medicine, medical director, heart failure program, Grady Memorial Hospital, moderated a joint session at the European Society of Cardiology with European and Egyptian cardiologists on how to close outcome gaps in cardiovascular care in ethnically diverse populations.
Share on Twitter Share on Facebook Share on Linkedin

How to close outcome gaps in cardiovascular care

Share on Twitter Share on Facebook Share on Linkedin
Anekwe Onwuanyi, MD, FACC, American Heart Association volunteer, Professor of Medicine and Chief of Cardiology, at Morehouse School of Medicine, medical director, heart failure program, Grady Memorial Hospital, moderated a joint session at the European Society of Cardiology with European and Egyptian cardiologists on how to close outcome gaps in cardiovascular care in ethnically diverse populations.
It's important to remember that there is no one-size-fits-all solution when it comes to patient care. What works is some communities may not work in others.
READ MORE >

Medical societies, aging advocates share early reactions to new TAVR policies

CMS just finalized significant changes to its TAVR coverage policies. Three leading cardiovascular health societies shared a joint statement summarizing their initial feedback. 

READ MORE >
Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists. female physician male
Share on Twitter Share on Facebook Share on Linkedin

Medical societies, aging advocates share early reactions to new TAVR policies

Share on Twitter Share on Facebook Share on Linkedin
Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists. female physician male
CMS just finalized significant changes to its TAVR coverage policies. Three leading cardiovascular health societies shared a joint statement summarizing their initial feedback. 
READ MORE >

Authorities raid cardiologists’ homes as part of fraud investigation

Multiple veteran cardiologists have been accused of accepting bribes from medtech companies. No arrests have been made at this time. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Authorities raid cardiologists’ homes as part of fraud investigation

Share on Twitter Share on Facebook Share on Linkedin
Multiple veteran cardiologists have been accused of accepting bribes from medtech companies. No arrests have been made at this time. 
READ MORE >

In Other News

Labcorp settles $2.3B data breach lawsuit brought by 44 states

The incident happened in 2019, when a third-party debt collector used by the diagnostics company had a hacker inside its network for over 8 months. In total, the incident exposed records from 27.5 million patients to hackers.

READ MORE >
cleveland clinic settles for failing to disclose research funding
Share on Twitter Share on Facebook Share on Linkedin

Labcorp settles $2.3B data breach lawsuit brought by 44 states

Share on Twitter Share on Facebook Share on Linkedin
cleveland clinic settles for failing to disclose research funding
The incident happened in 2019, when a third-party debt collector used by the diagnostics company had a hacker inside its network for over 8 months. In total, the incident exposed records from 27.5 million patients to hackers.
READ MORE >

FDA clears AI tool for pediatric bone age assessments

Bone age assessments are commonly used to evaluate whether a child's skeletal development is consistent with their chronological age.

READ MORE >
Hospital for Special Surgery pediatric MRI
Share on Twitter Share on Facebook Share on Linkedin

FDA clears AI tool for pediatric bone age assessments

Share on Twitter Share on Facebook Share on Linkedin
Hospital for Special Surgery pediatric MRI
Bone age assessments are commonly used to evaluate whether a child's skeletal development is consistent with their chronological age.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

CMS may cover TAVR for aortic regurgitation | FDA approves CardioMEMS updates | Lilly's GLP-1 pill | Celebrating outpatient care
September's Top Stories: BP drug recalled | Major TAVR changes | AI for heart attack detection | FDA approves small pacemaker
Making cardiologists feel safer | New SCAD research | Young children on GLP-1s | Heart attack drug submitted to FDA
Cardiology compensation climbs again | FDA OKs first heart valve of its kind | AI improves workflows | Rural practices struggle
AI scans routine images to evaluate risk | Looking back at ESC Congress 2026 | New ASNC recommendations | Building a CT program
FDA clears heart valve that grows with pediatric patient | Renal denervation assigned CPT I codes | Regenerating heart cells
Improving workflows with AI | Expert insights on heart-healthy diets | Startup's big news | Video tech cleared for new surgeries
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup